The embolic protection devices market has seen considerable growth due to a variety of factors.
• The embolic protection devices market has experienced strong growth. It will increase from $1.14 billion in 2024 to $1.24 billion in 2025, reflecting a CAGR of 8.6%.
The growth is driven by the increasing demand for advanced interventional techniques, an aging population, a growing healthcare infrastructure, higher investment in research and development, and a rise in clinical trials.
The embolic protection devices market is expected to maintain its strong growth trajectory in upcoming years.
• The embolic protection devices market is expected to see strong growth, reaching $1.7 billion by 2029 with a CAGR of 8.3%.
Factors driving this growth include increasing vascular procedures, more complex cardiovascular treatments, rising awareness of embolic risks, and the adoption of minimally invasive procedures. Trends include technological advancements, digital health, personalized medicine, bioresorbable materials, and next-gen filter technologies.
The increasing prevalence of cardiovascular disorders is expected to fuel the embolic protection devices market. Cardiovascular diseases, such as heart attacks and strokes, are rising due to lifestyle changes, urbanization, and poor dietary habits. Embolic protection devices reduce the risk of complications during cardiovascular procedures. The European Environment Agency reported in June 2023 that over 6 million new cases of cardiovascular diseases were diagnosed in the EU in 2022, propelling the growth of this market.
The embolic protection devices market covered in this report is segmented –
1) By Type: Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices
2) By Material: Nitinol, Polyurethane
3) By Application: Cardiovascular Disease, Neurovascular Disease, Peripheral Disease
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Distal Filter Devices: Balloon-Inflatable Filters, Non-Balloon Filters, Temporary Filters
2) By Distal Occlusion Devices: Balloon Occlusion Devices, Stent Occlusion Devices
3) By Proximal Occlusion Devices: Proximal Balloon Occlusion Devices, Proximal Mechanical Occlusion Devices
In the embolic protection devices market, companies are focusing on developing advanced technologies like 3-in-1 carotid stenting systems to improve patient outcomes by enhancing safety and procedure efficiency. The 3-in-1 carotid stenting system combines embolic protection, stenting, and balloon angioplasty into one device. For example, in October 2024, Contego Medical, a U.S.-based company, received FDA approval for its Neuroguard IEP System, which integrates a high-performance stent, dilation balloon, and embolic filter, enhancing the procedure's safety by capturing embolic particles that traditional systems may miss.
Major companies operating in the embolic protection devices market are:
• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• W L Gore & Associates Inc.
• Cook Medical LLC
• LivaNova PLC
• Cordis Corporation
• MicroPort Scientific Corporation
• Biotronik SE & Co. KG
• Endologix LLC
• Claret Medical Inc.
• Cardiovascular Systems Inc.
• Silk Road Medical Inc.
• CeloNova Biosciences Inc.
• Veryan Medical Ltd.
• Emboline Inc.
• Keystone Heart Ltd.
• InspireMD Inc.
• Innovative Cardiovascular Solutions LLC
• Allium Medical Solutions Ltd.
• Contego Medical LLC
• AngioSlide Ltd.
• Transverse Medical Inc
North America was the largest region in the embolic protection devices market in 2024. The regions covered in the embolic protection devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.